IYHvsPPH
iShares U.S. Healthcare ETF against VanEck Pharmaceutical ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IYH | PPH | |
|---|---|---|
| Expense ratio | 0.40% | 0.36% |
| Assets | $4B | $1B |
| Net flow, 1 month | +$337M | +$22M |
| Net flow, 1 year | +$576M | +$308M |
| Return, YTD | +8.6% | +4.8% |
| Return, 1 year | +16.1% | +15.4% |
| Avg daily volume | 619K | 294K |
| Holdings | 117 | 27 |
| Listed | Jun 12, 2000 | Feb 1, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS